Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ghosn

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
HIV Medicine|July 9, 2004
Acute hepatitis C in HIV-infected men who have sex with menJ Ghosn, S Pierre-François, V Thibault, et al.
The Journal of Antimicrobial Chemotherapy|June 10, 2021
Efficacy and tolerability of combined antiretroviral treatment with bictegravir/emtricitabine/tenofovir alafenamide initiated at the time of primary HIV infectionA Bachelard, V Isernia, D Vallois, et al.
The Journal of Antimicrobial Chemotherapy|September 18, 2014
HIV-1 subtype influences susceptibility and response to monotherapy with the protease inhibitor lopinavir/ritonavirK A Sutherland, J Ghosn, J Gregson, et al.
Neurology. Clinical Practice|May 13, 2026
Optimizing Antiseizure Medication Taper in the Epilepsy Monitoring UnitKerry C Nix, Nina J Ghosn, Kevin Xie, et al.
AIDS Care|March 17, 2020
How PrEP users constitute a community in the MSM population through their specific experience and management of stigmatization. The example of the French ANRS-PREVENIR studyC Puppo, B Spire, S Morel, et al.
HIV Medicine|April 28, 2007
Antiviral activity of low-dose alovudine in antiretroviral-experienced patients: results from a 4-week randomized, double-blind, placebo-controlled dose-ranging trialJ Ghosn, A-M Quinson, Nd Sabo, et al.
The Journal of Antimicrobial Chemotherapy|June 21, 2019
First year of pre-exposure prophylaxis implementation in France with daily or on-demand tenofovir disoproxil fumarate/emtricitabineM Siguier, R Mera, G Pialoux, et al.
Hepatology (Baltimore, Md.)|October 1, 1991
Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: their prevalence and clinical relevance. The VA Cooperative Study Group (No. 119)C L Mendenhall, L Seeff, A M Diehl, et al.
Brain : a Journal of Neurology|July 15, 2025
Comparative effectiveness of anti-seizure medications in emulated trials using medical informaticsKevin Xie, Jacob Korzun, Daniel J Zhou, et al.
Epilepsia|February 23, 2023
A pharmacokinetic model of antiseizure medication load to guide care in the epilepsy monitoring unitNina J Ghosn, Kevin Xie, Akash R Pattnaik, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
HIV Medicine|July 9, 2004
Acute hepatitis C in HIV-infected men who have sex with menJ Ghosn, S Pierre-François, V Thibault, et al.
The Journal of Antimicrobial Chemotherapy|June 10, 2021
Efficacy and tolerability of combined antiretroviral treatment with bictegravir/emtricitabine/tenofovir alafenamide initiated at the time of primary HIV infectionA Bachelard, V Isernia, D Vallois, et al.
The Journal of Antimicrobial Chemotherapy|September 18, 2014
HIV-1 subtype influences susceptibility and response to monotherapy with the protease inhibitor lopinavir/ritonavirK A Sutherland, J Ghosn, J Gregson, et al.
Neurology. Clinical Practice|May 13, 2026
Optimizing Antiseizure Medication Taper in the Epilepsy Monitoring UnitKerry C Nix, Nina J Ghosn, Kevin Xie, et al.
AIDS Care|March 17, 2020
How PrEP users constitute a community in the MSM population through their specific experience and management of stigmatization. The example of the French ANRS-PREVENIR studyC Puppo, B Spire, S Morel, et al.
HIV Medicine|April 28, 2007
Antiviral activity of low-dose alovudine in antiretroviral-experienced patients: results from a 4-week randomized, double-blind, placebo-controlled dose-ranging trialJ Ghosn, A-M Quinson, Nd Sabo, et al.
The Journal of Antimicrobial Chemotherapy|June 21, 2019
First year of pre-exposure prophylaxis implementation in France with daily or on-demand tenofovir disoproxil fumarate/emtricitabineM Siguier, R Mera, G Pialoux, et al.
Hepatology (Baltimore, Md.)|October 1, 1991
Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: their prevalence and clinical relevance. The VA Cooperative Study Group (No. 119)C L Mendenhall, L Seeff, A M Diehl, et al.
Brain : a Journal of Neurology|July 15, 2025
Comparative effectiveness of anti-seizure medications in emulated trials using medical informaticsKevin Xie, Jacob Korzun, Daniel J Zhou, et al.
Epilepsia|February 23, 2023
A pharmacokinetic model of antiseizure medication load to guide care in the epilepsy monitoring unitNina J Ghosn, Kevin Xie, Akash R Pattnaik, et al.
Pageof 4